Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

35.46
BATS BZX Real-Time Price
As of 2:05pm ET
 +0.46 / +1.31%
Today’s Change
31.08
Today|||52-Week Range
80.25
-53.82%
Year-to-Date
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
Sep 16 / Zacks.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Roche Ocrevus Positive in Phase III Multiple Sclerosis Trials
Sep 15 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Shire's Immunodeficiency Treatment Cuvitru Gets FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Xencor (XNCR) Doses First Patient in Myeloid Leukemia Trial
Sep 13 / Zacks.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content
Tesaro Gets Fast Track Designation for Ovarian Cancer Drug
Sep 13 / Zacks.com - Paid Partner Content